Skip to main content
logo
Tourmaline Bio, Inc. (TRML)
Oct 28, 2025 - TRML was delisted (reason: acquired by NVS)
47.98
0.00 (0.00%)
Inactive · Last trade price on Oct 27, 2025

Tourmaline Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
31.4230.51140.738.260.15
Short-Term Investments
207.81227.862.23--
Cash & Short-Term Investments
239.23258.3202.958.260.15
Cash Growth
-17.37%27.27%2357.63%5405.33%-
Prepaid Expenses
9.8710.545.920.05-
Total Current Assets
249.1268.84208.878.310.15
Property, Plant & Equipment
0.170.270.450.57-
Long-Term Investments
17.1836.63---
Other Long-Term Assets
2.843.260.970.22-
Total Assets
269.3309210.39.10.15
Accounts Payable
3.173.581.070.40.19
Accrued Expenses
6.785.13.710.80.03
Short-Term Debt
----0.15
Current Portion of Leases
0.150.230.220.16-
Total Current Liabilities
10.18.9151.360.38
Long-Term Leases
-0.020.190.34-
Other Long-Term Liabilities
0.010.020.06--
Total Liabilities
10.18.955.251.710.38
Common Stock
000--
Additional Paid-In Capital
440.39435.01267.020.2-
Retained Earnings
-181.32-135.26-62.05-19.93-0.23
Comprehensive Income & Other
0.120.30.07--
Total Common Equity
259.19300.05205.04-19.73-0.23
Shareholders' Equity
259.19300.05205.047.39-0.23
Total Liabilities & Equity
269.3309210.39.10.15
Total Debt
0.150.240.420.50.15
Net Cash (Debt)
239.09258.06202.547.75-
Net Cash Growth
-17.33%27.41%2512.02%--
Net Cash Per Share
9.2810.1842.678.84-
Filing Date Shares Outstanding
25.6925.6925.6510.8810.88
Total Common Shares Outstanding
25.6925.6220.3410.8810.88
Working Capital
239.01259.93203.876.95-0.23
Book Value Per Share
10.0911.7110.08-1.81-0.02
Tangible Book Value
259.19300.05205.04-19.73-0.23
Tangible Book Value Per Share
10.0911.7110.08-1.81-0.02
Machinery
-0.060.050.02-
Leasehold Improvements
-0.070.070.06-
Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q